This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (6)  • Contact me when this article is cited  Related Content  • Similar articles in this journal

Arch Ophthalmol. 1999;117:974.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

THE NEWLY announced International Trachoma Initiative (ITI) is the latest effort to eliminate blindness caused by trachoma. Of the 38 million blind people in the world, 6 million (15.5%) are blind because of trachoma and 11 million need eyelid surgery for trichiasis and entropion. One hundred fifty million children have the active, infectious form of trachoma, which can be controlled with antibiotic treatment.^1-2 Adults with scarred eyelids and children infected with Chlamydia trachomatis compose the reservoir for future generations of individuals who become blind because of trachoma.

In the past, the progression of infectious trachoma in childhood to eyelid distortion and blindness in adult life seemed inevitable. This is no longer the case because new developments in treating trachoma make control of trachomatous blindness a reality. These developments include a simplified system of trachoma assessment to identify communities that need antibiotic and surgical intervention³; the availability of the new . . . [Full Text of this Article]

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

THE GLOBAL ELIMINATION OF BLINDING TRACHOMA: PROGRESS AND PROMISE
KUMARESAN and MECASKEY
Am J Trop Med Hyg 2003;69:24-28.
ABSTRACT | FULL TEXT  

Growth and Development of Tetracycline-Resistant Chlamydia suis
Lenart et al.
Antimicrob. Agents Chemother. 2001;45:2198-2203.
ABSTRACT | FULL TEXT